🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 2 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 10/05/2021 | 80,90 | 80,90 | 78,42 | 79,01 | -3,03% | 3,06% | 241.572 |
| 07/05/2021 | 79,81 | 82,07 | 79,29 | 81,48 | +3,27% | 3,49% | 238.206 |
| 06/05/2021 | 81,16 | 81,16 | 77,41 | 78,90 | -2,86% | 4,62% | 328.294 |
| 05/05/2021 | 82,24 | 83,26 | 80,47 | 81,22 | -1,38% | 3,39% | 274.434 |
| 04/05/2021 | 82,59 | 85,46 | 81,25 | 82,36 | -9,10% | 5,09% | 498.052 |
| 03/05/2021 | 92,09 | 92,33 | 89,62 | 90,60 | -0,45% | 2,94% | 200.215 |
| 30/04/2021 | 90,00 | 93,24 | 89,98 | 91,01 | +0,08% | 3,63% | 196.207 |
| 29/04/2021 | 93,23 | 93,23 | 89,98 | 90,94 | -0,63% | 3,49% | 113.172 |
| 28/04/2021 | 93,37 | 93,54 | 91,15 | 91,51 | -2,91% | 2,56% | 127.118 |
| 27/04/2021 | 94,29 | 95,71 | 92,97 | 94,25 | +0,05% | 2,90% | 154.209 |
| 26/04/2021 | 91,15 | 94,64 | 90,86 | 94,20 | +3,28% | 4,14% | 155.812 |
| 23/04/2021 | 93,69 | 95,32 | 90,95 | 91,22 | -1,19% | 4,66% | 149.881 |
| 22/04/2021 | 95,20 | 96,69 | 91,79 | 92,31 | -2,71% | 5,15% | 179.055 |
| 21/04/2021 | 91,82 | 95,15 | 91,14 | 94,88 | +3,64% | 4,38% | 156.613 |
| 20/04/2021 | 90,53 | 92,31 | 89,48 | 91,55 | +0,52% | 3,13% | 210.153 |
| 19/04/2021 | 92,74 | 94,70 | 90,57 | 91,08 | -2,82% | 4,46% | 187.070 |
| 16/04/2021 | 93,69 | 94,76 | 92,54 | 93,72 | +0,91% | 2,37% | 177.612 |
| 15/04/2021 | 94,98 | 95,70 | 92,62 | 92,88 | -1,42% | 3,24% | 124.233 |
| 14/04/2021 | 92,13 | 95,88 | 92,09 | 94,22 | +2,74% | 4,11% | 187.230 |
| 13/04/2021 | 90,56 | 93,28 | 88,68 | 91,70 | +1,45% | 5,08% | 177.612 |
| 12/04/2021 | 95,30 | 95,86 | 90,34 | 90,39 | -5,57% | 5,80% | 272.189 |
| 09/04/2021 | 96,33 | 97,36 | 95,13 | 95,72 | -1,41% | 2,31% | 186.750 |
| 08/04/2021 | 96,26 | 98,33 | 96,26 | 97,09 | +1,47% | 2,15% | 224.260 |
| 07/04/2021 | 95,51 | 97,22 | 94,40 | 95,69 | -0,49% | 2,95% | 227.786 |
| 06/04/2021 | 95,79 | 99,79 | 95,79 | 96,16 | +0,41% | 4,18% | 212.237 |
| 05/04/2021 | 98,32 | 98,32 | 94,85 | 95,77 | -0,70% | 3,52% | 182.742 |
| 01/04/2021 | 96,25 | 97,81 | 94,63 | 96,44 | +1,41% | 3,31% | 192.841 |
| 31/03/2021 | 93,57 | 98,06 | 93,57 | 95,10 | +2,24% | 4,79% | 262.892 |
| 30/03/2021 | 92,16 | 94,38 | 91,39 | 93,02 | +0,12% | 3,24% | 132.248 |
| 29/03/2021 | 95,35 | 96,66 | 90,83 | 92,91 | -2,96% | 6,11% | 158.376 |